CoChat

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

Eikelenboom, P., Veerhuis, R. · 1996 · Neurobiology of Aging

The DOI matches its Crossref record; 97 of the 100 references it cites were found in a registry or an index.

Abstract

A variety of inflammatory mediators including complement activation products, protease inhibitors, and cytokines are colocalized with beta-amyloid (A beta) deposits in the Alzeimer's disease (AD) brain. Activation products of the early complement components C1, C4, and C3 are always found in neuritic plaques and to a lesser extent in varying numbers of diffuse plaques. In contrast to these findings, no immunohistochemical evidence was obtained for the presence of the late complement components C7 and C9 and the complement membrane attack complex in the neuropathological lesions in AD brains. The mRNA encoding the late complement components C7 and C9 appears to be hardly or not detectable. These findings indicate that in AD the complement system does not act as an inflammatory mediator through membrane attack complex formation, but through the actions of the early complement products. In this review we focus on the role of complement in the pathological amyloid cascade in AD. In our opinion, the early complement activation products play a crucial role as mediators between the A beta deposits and the inflammatory responses leading to neurotoxicity.

Overview

Integrity signals

Registry

Crossref · 10.1016/0197-4580(96)00108-x

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 97 references

Research works printed but not linked: 3

  1. Mehne, 1976, Ein serogenetische Beitrag zur ätiopathogenese der Alzheimerischen Erkrankung, Akt. Geront., 6, 259
  2. Veerhuis, 1995, Immunolocalization of receptors for the globular and collagen region of the complement component C1q in Alzheimer disease brain, Soc. Neurosci. Abstr., 21, 147
  3. Zhan, 1994, Immunohistochemical distribution of the inhibitors of the terminal complement complex in Alzheimer's disease, Neurodegeneration, 3, 111

Cited by

See all 206

Metadata

Authors
Eikelenboom, P., & Veerhuis, R.
Affiliations
Vrije Universiteit Amsterdam (NL)
Corresponding author
Eikelenboom, P.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
1996-09
Volume
17
Issue
5
Pages
673-680
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2026303819
Cited by
206
References
100
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 7 · 2013: 9 · 2012: 9
FWCI
7.11
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, complement system, activated microglia, amyloid-beta, neuritic plaques, complement activation products, membrane attack complex, neuroinflammation, neurotoxicity, amyloid hypothesis, protease inhibitors, cytokines
MeSH terms
Alzheimer Disease, Brain, Complement System Proteins, Humans, Inflammation, Macrophage Activation, Microglia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/0197-4580(96)00108-x
The paper
Eikelenboom, P., & Veerhuis, R. (1996). The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/0197-4580(96)00108-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.